Postoperative Troponin in Children With Congenital Heart Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01616394

Enrollment

180

Registered

2012-06-11

Start date

2012-02-29

Completion date

2014-10-31

Last updated

2014-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Brief summary

The aim of the study is to evaluate the value of postoperative troponin in the prediction of mid term and long term mortality and morbidity in children with congenital heart disease undergoing cardiac surgery.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 10 Years

Healthy volunteers

Inclusion criteria

* all children with congenital heart disease between 0-10 years admitted for elective or emergency corrective or palliative cardiac surgery

Exclusion criteria

* parental refusal * children older than 10 years

Design outcomes

Primary

Measure	Time frame
mortality	3 months

Secondary

Measure	Time frame
morbidity and mortality and length of stay in the PICU and in the hospital	in hospital; 3 months; 6 months

Countries

Belgium

Outcome results